论文部分内容阅读
近年来国内、外报道小剂量阿糖胞苷(ARA—C)可使急性粒细胞白血病缓解,为进一步观察其疗效,我们自1984年8月到1985年3月采用小剂量ARA—C治疗6例急性非淋巴细胞白血病(ANLL),3例骨髓增生异常综合症(MDS),现总结如下。 临床资料 一、治疗对象:本组9例均为确诊患者。男7例,女2例;年龄16～69岁;初治者6例,复治者3例。 细胞类型为粒细胞白血病未分化型
In recent years, domestic and foreign reports of small doses of cytarabine (ARA-C) can be alleviated acute myeloid leukemia, in order to further observe its efficacy, we from August 1984 to March 1985 with low-dose ARA-C treatment 6 Cases of acute non-lymphocytic leukemia (ANLL), 3 cases of myelodysplastic syndrome (MDS), are summarized as follows. Clinical data First, the treatment of patients: the group of 9 patients were diagnosed. 7 males and 2 females; aged from 16 to 69 years old; 6 cases of initial treatment, and 3 cases of retreatment. The cell type is myeloid leukemia undifferentiated